Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial

Dennis T Ko1, Clare L Atzema, Linda R Donovan

  • 1Division of Cardiology, Schulich Heart Centre, University of Toronto, Ontario, Canada. dennis.ko@ices.on.ca

Insights

Rescue percutaneous coronary intervention (PCI) significantly lowers long-term adverse outcomes for ST-segment elevation myocardial infarction (STEMI) patients who fail fibrinolysis. Despite benefits, this crucial reperfusion strategy is underused in clinical practice.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Fibrinolytic therapy is a primary reperfusion strategy for ST-segment elevation myocardial infarction (STEMI).
  • Limited data exist on rescue percutaneous coronary intervention (PCI) use, its predictors, and long-term outcomes in STEMI patients with failed fibrinolysis.

Purpose of the Study:

  • To analyze the utilization patterns of rescue PCI in STEMI patients experiencing failed fibrinolysis.
  • To identify factors associated with rescue PCI use.
  • To evaluate the impact of rescue PCI on long-term adverse outcomes.

Main Methods:

  • Observational analysis of a population-based cohort of 2,953 STEMI patients in Ontario, Canada (2004-2005).
  • Failed fibrinolysis defined as <50% ST-segment resolution at 60-90 minutes post-therapy.
  • Primary endpoint: death or repeat acute coronary syndrome hospitalization at 4 years.

Main Results:

  • 40.3% of fibrinolysis-treated STEMI patients (611/1517) failed therapy.
  • Rescue PCI was used in 34.7% of these patients (212/611); conservative management in 61.1%; repeat fibrinolysis in 4.3%.
  • Initial presentation to a PCI-capable hospital strongly predicted rescue PCI use (OR 3.7). Rescue PCI was associated with a 31% reduction in long-term adverse events (aHR 0.69), primarily driven by reduced mortality (HR 0.60).

Conclusions:

  • Rescue PCI significantly reduces long-term adverse outcomes, including death, in STEMI patients with failed fibrinolysis.
  • Despite proven benefits, rescue PCI remains substantially underutilized in current clinical practice.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...